ACEM Primary
Cardiovascular Pathology

Cardiovascular Pathology

Blood Vessels

  • Basic constituents include endothelial cells, smooth muscle + ECM (elastin, collagen, glycosaminoglycans)
  • 3 layers:
    • Intima = single layer endothelial cells on BM, underlaid by thin ECM. Separated from media by internal elastic lamina.
    • Media = smooth muscle, varies according to functional demands
    • Adventitia = loose connective tissue with nerve fibres and vasa vasorum
  • 3 types:
    • Large (elastic) such as aorta
    • Medium (muscular) smaller aortic branches
    • Small (<2mm diameter) arteries and arterioles
  • Veins = less rigid walls so can dilate and compress, reverse flow prevented by valves

Atherosclerosis

  • Risk factors include:
    • Modifiable = cholesterol, smoking, hypertension, diabetes
    • Non modifiable = LDL receptor gene mutations, age 40-60 years, gender
    • Other = inflammation, hyperhomocysteinaemia, metabolic syndrome, lipoprotein A or factors affected haemostasis
  • Atheromas = intimal lesions consist of soft, yellow lipid core with white fibrous cap -> protrude into vessel lumen
  • Grow slowly over decades, plaques can be stable (dense fibrous cap, minimal lipid accumulation = chronic ischaemia sx by narrowing lumens) or unstable (thin caps, large lipid cores and dense inflammatory infiltrates = fatal ischaemic complications)
  • Three principal components:
    • Smooth muscle cells, macrophages and T cells
    • ECM
    • Intra/extracellular fluid
  • Pathologic changes:
    • Mechanically obstruct blood flow
    • Haemorrhage into plaque may expand it or induce rupture
    • Atheroembolism -> microemboli
    • Rupture to exposed tissue factor and lead to thrombosis
    • Weaken underlying media -> aneurysm formation
    • Healing of subclinical plaques + resorption of overlying thrombi 
  • Pathogenesis: “Response to injury” hypothesis = chronic inflammatory and healing process of arterial wall to endothelial injury
    • Endothelial injury and dysfunction
      • Causes: haemodynamic disturbance, hypercholesterolaemia (increased LDL/ decreased HDL/increased lipoprotein A)
      • Inflammation is triggered by accumulation of cholesterol cystals + FFA in macrophages
    • Accumulation of lipoproteins
    • Monocyte adhesion to endothelium
    • Platelet adhesion
    • Factor release
    • Smooth muscle proliferation, ECM production and recruitment of T cells
      • Convert fatty streak (lipid filled macrophage) -> mature atheroma
    • Lipid accumulation
  • Vessels involved = lower abdominal aorta, coronaries, popliteal arteries, ICA and circle of willis
  • Consequences = MI, CVA, AAA, PVD, mesenteric ischaemia
    • Plaques responsible for MI/ ACS are often asymptomatic prior to acute change, such as
      • Adrenergic stimulation associated with wakening can cause BP spikes + heightened PLT reactivity -> circadian periodicity for AMI (0600-1200)
      • Acute emotional stress
    • Vasoconstriction can potentiate plaque disruption by increasing local mechanical forces
      • Stimulated by adrenergic activity, locally released PLT contents, endothelial cell dysfunction, mediators from perivascular inflammatory cells

Aneurysms and Dissections

Aneurysm = localised abnormal dilatation in blood vessel/ heart that may acquired or congenital

Occur when structure/ function of connective tissue is compromised.

  • Inherited defects:
    • Marfans (defective synthesis of scaffolding protein fibrillin)
    • Ioeys- Dietz (defective elastin/ collagen I and III synthesis)
    • Ehlers-Danlos (defective collagen III synthesis)
    • Vitamin D deficiency (altered collagen cross linking)
  • Acquired:
    • Atherosclerosis
    • Hypertension
    • Other = trauma, vasculitis, infection (mycotic aneurysm = embolization of septic embolus eg. Complication of IE OR extension of adjacent suppurative process OR circulating organisms directly infiltrating vascular wall)
  • Vascular wall weakened through loss of smooth muscle cells or synthesis of non- collagenous/ elastic ECM:
    • Ischaemia of inner media when atherosclerotic thickening occurs of intima
    • Systemic hypertension narrows vasa vasorum
  • Types:
    • True = attenuated but intact artery wall or thinned heart ventricle
      • Saccular (spherical outpouchings involving only portion of vessel wall, often contain thrombus)
      • Fusiform (diffuse circumferential dilations of long vascular segment)
        • Atherosclerotic/ syphilitic/ congenital vascular aneurysms
        • LV aneurysm post MI
    • False (pseudo) aneurysm = defect in vascular wall -> extravascular haematoma that freely communicates with intravascular space (pulsating haematoma)
      • Leak at sutured junction of vascular graft with natural artery
      • Ventricular rupture contained by pericardial adhesion
  • Abdominal aortic aneurysm
    • Occur more frequently in men, smokers post age 50
    • Positioned below renal arteries and above bifurcation of aorta
    • Saccular or fusiform
    • Frequently contains bland, poorly laminated mural thrombus -> can affect renal/ superior or inferior mesenteric arteries by direct extension or mural thrombi
    • Sx: asymptomatic/ incidental, rupture with massive haemorrhage, obstruction of branching vessel causing mesenteric/ renal/ iliac ischaemia
    • Risk of rupture related to size:
      • <4cm = nil risk
      • 4-5cm = 1% per year
      • 5-6cm = 11% per year
      • >6cm = 25% per year
    • Most expand 0.2-0.3cm per year, ~20% more aggressive
    • Aneurysms >5cm managed surgically
  • Thoracic aortic aneurysm
    • Associated with hypertension
    • Sx: respiratory difficulties (encroachment on lungs/airways), dysphagia (compression of oesophagus), persistent cough (compression recurrent laryngeal nerves), pain (erosion of bone), cardiac disease (AV valve dilatation with insufficiency or narrowing coronary ostia), rupture

Dissection = blood separates laminar planes of media to form blood filled channel within aortic wall

  • Hypertension main risk factor -> hypertrophy of vasa vasorum + degenerative change in ECM (cystic medial degeneration)
  • If ruptures through adventitia, haemorrhage can be catastrophic
  • Affects:
    • Men aged 40-60 years with antecedent hypertension (>90% cases)
    • Younger adults with connective tissue diseases affecting aorta
    • Iatrogenic following CABG
    • Pregnancy related in third trimester (rare)
  • Morbidity and mortality depend on part of aorta involved: more serious if dissection between aortic valve and distal arch
  • Types:
    • Ascending (DeBakey II) +/- descending aorta (DeBakey I)
      • More common and dangerous
      • Require rapid diagnosis and surgical rx
    • Type B = distal to subclavian artery (DeBakey III)
      • Conservative rx
  • Sx: Excruciating chest pain radiating to the back -> rupture into pericardial/ pleural or peritoneal spaces = tamponade or aortic insufficiency

Hypertensive vascular disease

  • Hypertension:
    • 5% secondary due to underlying renal or adrenal disease
    • 95% idiopathic “essential” hypertension
  • Major risk factor for atherosclerosis, CCF, renal failure
  • Physiology:
    • BP = CO x TPR
      • TPR regulated at level of arterioles influenced by neural and hormonal inputs. Vascular tone = balance between vasoconstrictors (angiotensin II, catecholamines, inflammatory chemicals) and vasodilators (kinins, PGs and NO)
      • Resistance vessels also exhibit autoregulation = blood flow induced vasoconstriction to protect tissues against hypoxia
      • Fine-tuned by tissue pH, hypoxia, a and b adrenergic systems to accommodate local metabolic demands
      • CO determined by HR/ SV ß blood volume ß renal sodium excretion or resorption
  • Normal regulation:
    • Reduced blood volume -> decreased glomerular blood flow and pressure in afferent arteriole -> increased reabsorption of sodium by PCT -> renin secretion -> RAAS pathway
    • Natriuretic factors (ANP/ BNP) respond to volume expansion to inhibit sodium reabsorption in DCT -> sodium and water excretion + vasodilation
  • Essential HTN: Complex and multifactorial
    • Genetic factors influence BP regulation
    • Reduced renal sodium excretion in presence of normal arterial pressure may be key initiating event
    • Vasoconstrictive influences -> increased TPR
    • Environmental = stress, obesity, smoking, physical inactivity and heavy salt consumption
  • Secondary HTN:
    • Renovascular – renal artery stenosis/ acute glomerulonephritis/chronic renal failure/polycystic kidney disease/vasculitis/renin-secreting tumors
      • liquorice ingestion
      • Exogenous = glucocorticoids, oestrogen, sympathomimetics, MAO-I
      • Phaeochromocytoma
      • Acromegaly
      • Hypo/ hyperthyroidism
      • Pregnancy induced
    • CVS – coarctation of aorta, polyarteritis nodosa, increased intravascular volume, increased CO, rigidity of aorta
    • Neurologic – psychogenic, increased ICP, sleep apnoea, acute stress (surgery)
  • Genetic disorders:
    • Gene defects in aldosterone metabolism
    • Mutations affecting proteins in change of sodium reabsorption (Liddle syndrome)
  • Histologically:
    • Hyaline arteriosclerosis = thickening of arterial walls caused by hyaline deposits + proliferation of smooth muscle cells and reduplication of basement membranes
    • Hyperplastic arteriosclerosis = malignant HTN, “onion skin lesions” concentric laminated thickening of walls + luminal narrowing

The Heart

Cardiomyopathy

  • Intrinsic cardiac muscle disease
  • 3 categories:
    • Dilated (90%) = systolic dysfunction (contractile)
      • Caused by myocarditis, ETOH, pregnancy or genetic cytoskeletal protein defects (tintin mutation)
      • Myocarditis due to inflammatory infiltrates (coxsackie A/B viruses) -> acute heart failure -> dilated CMP
    • Hypertrophic = diastolic dysfunction
      • Autosomal dominant mutations in contractile proteins
    • Restrictive = stiff, non compliant myocardium
      1. Amyloid, radiation or endomyocardial scarring

Pericardial disease

  • Cause fluid accumulation, inflammation, fibrous constriction in association with cardiac or systemic disease:
    • Infective = viral, pyogenic bacteria, TB, fungi
    • Immunological = rheumatic fever, SLE, scleroderma, drug hypersensitivity reaction
    • Miscellaneous = MI (Dressler), uraemia, post cardiac surgery, neoplasia, trauma or radiation

Congestive heart disease

= Heart unable to pump blood to meet metabolic demands of body

Adaptive mechanisms

  • Frank-Starling mechanism = increased filling volumes dilate heart -> increase functional cross bridge formation within sarcomeres -> enhance contractility
  • Ventricular remodelling = hypertrophy or chamber dilation
  • Neurohumoral
    • NE -> b R -> increases HR and contractility
    • RAAS and ANP -> adjust filling volumes/ pressures

Pathophysiology:

  • Pressure/ volume overload + regional dysfunction
    • Hypertension
    • Valvular disease
    • MI
  • Causes increased cardiac work -> wall stress -> cell stretch -> hypertrophy/ dilation
  • Pressure- overload hypertrophy = sarcomeres positioned in parallel -> concentric hypertrophy -> increased ventricular wall thickness
  • Volume-overload hypertrophy = sarcomeres positioned in series -> eccentric hypertrophy -> ventricular dilation
    • Increased heart size and mass
    • Increased protein synthesis and abnormal proteins
    • Induction of immediate- early genes and foetal genes
    • Fibrosis
    • Inadequate vasculature
  • Cardiac dysfunction = heart failure, arrythmias, neurohumoral stimulation

Left HF

  • Causes = IHD, HTN, aortic and mitral valve disease, myocardial infiltrative disorders 
  • Congestion of pulmonary circulation + stasis of blood in left chambers + hypoperfusion of tissues and organ dysfunction
  • Morphology
    • Heart = cardiac myocyte hypertrophy + dilation in ventricle and atria (leading to AF/ LA thrombus) + stenotic, deformed valves
    • Lungs = perivascular and interstitial oedema (interlobular septa = Kerley B lines on CXR) -> oedematous widening of alveolar septa -> fluid in alveoli -> extravasation of RBC and phagocytosis by macrophages forming hemosiderin laden macrophage/ “heart failure cells”
  • Sx
    • Cough, dyspnoea, orthopnoea, PND
    • Atrial fibrillation
    • Pulmonary oedema (Decreased CO -> decreased renal perfusion -> activation RAAS -> retention of Na/ water -> expansion of volumes)
  • Classification
    • Systolic = insufficient CO (pump failure)
    • Diastolic = CO preserved, however LV abnormally stiff and unable to relax during diastole, impaired filling. Unable to increase CO in response to increased metabolic demands. Can lead to flash APO.

Right HF

  • Mostly caused by left HF
  • Pure right HF is infrequent, called Cor Pulmonale
  • Causes = pulmonary hypertension, PE, OSA, altitude sickness
  • Systemic venous congestion
  • Morphology
    • Heart = right sided hypertrophy/ dilation + valvular abnormalities, endocardial fibrosis (carcinoid heart disease)
    • Liver = congestive hepatomegaly (congestion around central veins within hepatic lobules = nutmeg liver) + centrilobular necrosis ->  cirrhosis
    • Pleural/ pericardial/ peritoneal space = fluid accumulation
    • Subcutaneous tissue = oedema, anasarca
  • Sx
    • Hepatosplenomegaly
    • Peripheral oedema
    • Pleural effusion, ascites

Often biventricular failure is present.

Standard therapy

  • Relieve fluid overload (diuretics)
  • Block RAAS (ACE I/ ARB)
  • Lower adrenergic tone (BB)

Ischaemic Heart Disease

Clinical syndromes = MI, angina pectoris, chronic IHD with heart failure, sudden cardiac death

Contributing factors = coronary atherosclerosis, coronary emboli, blockage of myocardial blood vessels

Aggravating factors = increased cardiac energy demand (tachycardia) or diminished blood/ oxygen (shock, hypoxia)

Pathogenesis = insufficient coronary perfusion relative to myocardial demand due to atherosclerotic narrowing of coronary arteries + plaque rupture + vasospasm

  • Chronic atherosclerosis
    • Fixed obstruction leading to stenosis
    • >75% lumen -> ischaemia with exercise, 90% lumen -> ischaemia at rest
    • LAD/ LCx/ RCA +/- epicardial branches
  • Acute plaque change
    • Rupture – superficial erosion – ulceration – fissuring or deep haemorrhage
    • Superimposed thrombus partially or completely occludes affected artery
  • Consequences:
    • Stable angina = nil plaque disruption, fixed coronary artery obstruction
    • Unstable angina = plaque rupture + partially occlusive thrombus -> severe transient reductions in flow
    • MI = plaque rupture + totally occlusive thrombus -> myocardial death
    • Sudden death = myocardial ischaemia which leads to fatal ventricular arrhythmia

Angina Pectoris

= Caused by transient myocardial ischaemia without myocyte necrosis

Four patterns:

  1. Stable (typical) = imbalance coronary perfusion due to chronic atherosclerosis) relative to myocardial demand -> produced by exercise/emotional excitement. Relieved by rest or GTN.
  2. Prinzmetal variant = coronary artery vasospasm, unrelated to exercise/ HR/ BP. Responds to vasodilators.
  3. Unstable (crescendo) = pattern of increasingly frequent pain, often prolonged, precipitated by lower levels of physical activity or at rest. Mostly caused by plaque disruption = warning that acute MI may be imminent.
  4. Silent ischaemia

Myocardial infarction

= Caused by death of cardiac muscle in setting of prolonged ischaemia

Pathogenesis:

  • Coronary arterial occlusion
    • Acute plaque change -> platelet adherence/ activation forming microthrombi + vasospasm -> TF activates coagulation cascade forming bulk of thrombus -> occlusion of vessel
    • Transmural MI (10% cases) due to vasospasm (cocaine use), emboli (LA thrombus, IE vegetations, paradoxical through patent FO), vasculitis
  • Myocardial response:
    • Reversible changes:
      • Cessation of aerobic metabolism – lack of ATP within seconds
      • Myofibrillar relaxation + glycogen depletion + cell swelling
      • Loss of contractility ~2 mins 
    • Irreversible changes (20-40 min)
      • Necrosis of myocytes
      • Disruption of sarcolemmal membrane -> intracellular macromolecules leak out (troponin)
    • Zone of necrosis = subendocardium which then extends to myocardium
  • Zones of perfusion: “Area at risk”
    • LAD – apex, anterior LV and anterior 2/3 ventricular septum
    • Dominant RCA vs LCx:
      • R dominant (majority) = RCA supplies RV free wall + posterobasal LV wall + posterior 1/3 septum and LCx supplies lateral LV wall
  • Transmural = full thickness (STEMI) vs Subendocardial = limited to inner 1/3-1/2 wall (NSTEMI)
    • RCA obstruction usually involve posterior free wall LV and RV wall

Morphology

TimeGrossLight microscopyElectron microscopy
Reversible injury
0-30 minNoneNoneRelaxation of myofibrils Glycogen depletion Mitochondrial swelling
Irreversible injury
4-12 hrDark mottlingEarly coagulation necrosisSarcolemma disruption Mitochondrial densities
12-24 hrNeutrophilic infiltrate 
3-7 daysYellow-tan infarctDisintegration of dead myofibers 
7-10 daysFibrovascular granulation tissue 
10-14 daysRed-grey infarct bordersAngiogenesis Collagen deposition 
>2 monthsScarScar 

Interventions to limit infarct size

= Reperfusion to salvage ischaemic myocardium

  • Coronary interventions include PCA, thrombolysis, angioplasty or CABG
  • Effectiveness depends on timing and degree of reperfusion restored
  • Complications associated such as arrhythmia, reperfusion injury, myocardial stunning (state of reversible heart failure) or haemorrhage
  • Morphology of re-perfused infarct = haemorrhagic (injured vasculature leaks when flow restored)
    • Irreversibly injured myocytes contain “contraction bands” = closely packed sarcomeres with eosinophilic infiltrate -> due to exaggerated contraction post reperfusion
  • Other therapy:
    • Aspirin, heparin = prevent further thrombosis
    • Oxygen = minimize ischaemia
    • Nitrates = systemic vasodilation, reduced cardiac workload, prevent vasospasm
    • Beta blockers = reduce cardiac oxygen demand, decrease arrhythmia risk
    • ACE I = limit ventricular dilation

Clinical features and laboratory testing

  • Cardiac specific proteins troponin I and T
    • Rise at 2-4 hours and peak at 48 hours
    • Persist for 7-10 days post MI
  • CK-MB (MB isoform in cardiac muscle) is sensitive not specific
    • Rise at 2-4 hours and peak at 24 hours
    • Normalises 72 hours
  • Both troponin and CK peak earlier in patients who are successfully re-perfused because they are washed out of cells more rapidly
  • Unchanged levels of troponin and CK over 2 days, excludes MI as diagnosis

Complications

  • LV dysfunction, cardiogenic shock
  • Arrhythmias – myocardial irritability
  • Myocardial rupture – rupture of LV free wall with haemopericardium and tamponade, rupture of septum or papillary muscle. Occurs 3-7 days post MI.
  • Pericarditis – Dressler’s Syndrome, 2-3 days post MI.
  • RV infarction or infarct extension/ expansion
  • Mural thrombus
  • Ventricular aneurysm

Chronic IHD

= Appears post infarction due to functional decompensation of hypertrophied non infarcted myocardium

  • Leads to CCF

Sudden Cardiac Death

= Unexpected death from cardiac causes in individuals without symptomatic heart disease or early after symptom onset (within 1 hour usually)

  • Consequence of fatal arrhythmia in setting of AMI
  • Other causes:
    • Congenital coronary abnormalities, AV stenosis, MVP, myocarditis, CMP, pulmonary HTN, cardiac hypertrophy, miscellaneous (drugs)
    • Hereditary or acquired cardiac arrythmias  = Long QT, Brugada, short QT, catecholaminergic polymorphic VT, WPW and sick sinus
      • Channelopathies = mostly autosomal dominant inheritance, involve Na/K/Ca channels -> Long QT

Valvular Heart Disease

= Stenosis (failure of valve opening) or regurgitation (failure of valve closing)

  • Functional regurgitation = secondary to weak support structure
    • MVR due to dilated LV
  • Clinical consequences depend on valve involved, degree of impairment, tempo of disease onset and quality of compensation mechanisms
Valve lesionMurmurAetiology
ASEjection systolic, crescendo/ decrescendo with radiation to carotidsSenile calcific AV “wear and tear”
Mounded calcified masses on cusps
No commissural fusion
Cause obstruction to LV outflow -> reduced CO Sx angina, syncope, CCF
Rx medical + surgical valve replacement
Congenital bicuspid AV
– Chr 18q, 13q and 5q
– Can become incompetent secondary to aortic dilation, cusp prolapse or IE
Post inflammatory scarring (RHD)
ARSoft high pitched, early diastolic decrescendo @ 3rd ICS (Erb point) on expirationPost inflammatory scarring (RHD)  
Degenerative aortic dilation
Syphilitic aortitis
Ankylosing spondylitis
RA
Marfan syndrome
MSLow pitch, rumbling diastolic murmur @ apexPost inflammatory scarring (RHD)  
MR    Mid-systolic click + mid-late systolic murmurPost inflammatory scarring (RHD)
IE
MVP “Myxomatous Degeneration of MV”
– “Floppy” leaflets which balloon backwards into LA in systole
Caused by connective tissue disorders (Marfan)
Morphology = deposition of mucoid myxomatous material
Sx = non exertional chest pain, dyspnoea or asymptomatic
Complications =
IE, progress to MR, stroke, arrhythmia 
Rupture papillary muscle or chordae tendinae  
LV enlargement (myocarditis, dilated CMP) Calcification mitral ring

Rheumatic Heart Disease

  • Acute immunologically mediated inflammatory disease occurring few weeks after Group A Streptococcal Pharyngitis -> valvular disease
  • Virtually the only cause of MS
  • Antibodies directed against streptococcal M proteins recognise cardiac self antigens
  • Morphology =
    • Acute RF
      • Aschoff bodies = foci T cells + activated macrophages (Anitschkow cells) + diffuse inflammation ~ pancarditis
      • Necrotic focal vegetations (verrucae)
      • Subendocardial thickenings (MacCallum plaques) in LA
    • Chronic RHD
      • Leaflet thickening
      • Commissural fusion
      • Thickening and fusion of tendinous cords
    • Can be mitral valve (2/3 cases) + AV (1/4 cases) + tricuspid (infrequent) + pulmonary (rare)
  • Clinical features:
  • Acute RF: occur 10 days to 6 weeks post initial infection
    • Migratory polyarthritis
    • Pancarditis = pericardial friction rub, arrhythmia, tachycardia
    • Subcutaneous nodules
    • Erythema marginatum
    • Sydenham chorea
  • Chronic RHD: years- decades
    • Cardiac murmurs, hypertrophy + dilatation, CCF
    • Atrial fibrillation, mural thrombus

Infective Endocarditis

  • Microbial infection of valves or mural endocardium -> vegetations composed of thrombotic debris + organisms + destruction of cardiac tissues
  • Classified:
    • Acute = infection of previously normal heart with highly virulent organism (staph aureus) which rapidly produces necrotic tissues. Can lead to death, requires urgent IV/ surgery.
    • Subacute = organisms with lower virulence (strep viridans) that cause insidious infections of deformed valves with less destruction. Protracted course weeks to months, cure with Abx.
  • Organisms:
    • Strep viridans = commensal in oral cavity
    • Staph aureus = IVDU
    • Staph epidermidis = prosthetic valves
  • Clinical features: Fever, chills, weakness + new murmur + microthromboemboli (if longstanding) with splinter haemorrhages/ Janeway lesions (non-tender in palms or soles)/ Oslers nodes (subcutaneous nodules in pulp of digits)/ Roth spots (retinal eye haemorrhages)

Non infected vegetations

  1. Non-bacterial thrombotic endocarditis
  2. Small sterile thrombi on cardiac leaflets ~1-5mm
  3. Found in debilitated patients with cancer or sepsis
  4. SLE “Libman- Sacks endocarditis”
  5. Mitral and tricuspid valvulitis
  6. Lesions 1-4mm located on undersurfaces of valves, endocardium/ chords

Carcinoid Heart Disease

  • Carcinoid syndrome = flushing, diarrhoea, dermatitis, bronchoconstriction caused by biochemical compounds (serotonin) released by carcinoid tumour
  • Cardiac lesions do not occur until there is large hepatic metastatic burden, as liver usually catabolizes circulating mediators before they reach the heart
  • Endocardium and valves R) heart plaques develop 

Complications of prosthetic valves (mechanical and tissue)

  • Thromboembolism
  • Structural deterioration
  • IE
  • Inadequate healing causing paravalvular leak
  • Exuberant healing causing obstruction

Last Updated on August 20, 2021 by Andrew Crofton

,